KIT and ovarian carcinoma: In our study, the c-Kit-mediated upregulation of cancer stemness-related Notch3—PBX1 and β-catenin—ABCG2 signaling pathways and promotion of ovarian cancer tumorigenicity and drug resistance were all phospho-PHBY259 dependent.